Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor.
D000941:Antigens; D055598:Chemical Phenomena; D002621:Chemistry; D005337:Fibrin / Q000276:immunology; D005340:Fibrinogen / Q000276:immunology / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D005971:Glutamates / Q000378:metabolism; D006801:Humans; D008239:Lysine / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D013997:Time Factors; D014148:Tranexamic Acid / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology; D000979:alpha-2-Antiplasmin / Q000172:deficiency*
D000941:Antigens; D005971:Glutamates; D000979:alpha-2-Antiplasmin; D014148:Tranexamic Acid; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator; D008239:Lysine